TPG Gallery-The only authorized Shutterstock distributor in Taiwan

Pre-filled pen of Risankizumab medication. Marketed as Skyrizi, Risankizumab is a humanised monoclonal antibody that binds to interleukin 23A (IL-23A) and blocks the activity of pro-inflammatory cytokines. Risankizumab is used to treat moderate to severe plaque psoriasis and active psoriatic arthritis. It is administered by a subcutaneous injection.

XL
Sketch

dpi

Details

Creative#:

TOP27562877

Source:

達志影像

Authorization Type:

Release Information:

須由TPG 完整授權

Model Release:

N/A

Property Release:

N/A

Right to Privacy:

Same folder images:

Same folder images

Restriction:

Editorial use only

Account：
Password：
Confirm Password：
User Type：
Full Name：
Phone：
Email：
Company：
Latest Location：
Currency：
Language：
Postal Code：
Address：
Industry：

Account：

Password：

Confirm Password：

User Type：

Full Name：

Phone：

Email：

Company：

Latest Location：

Currency：

Language：

Postal Code：

Address：

Industry：

Subscribe to non-watermark images
Subscribe to Editorial Content
Subscribe E-Journal
Gender：
Fax：
Mobile Phone：
Department：
Title：
Country：
Province：
City：
Bank：
Sub-Branch：
Bank Account：

Subscribe to non-watermark images

Subscribe to Editorial Content

Subscribe E-Journal

Gender：

Fax：

Mobile Phone：

Department：

Title：

Country：

Province：

City：

Bank：

Sub-Branch：

Bank Account：

Details

Select your country or region

選擇您的語言